Cranswick has reported a strong set of full-year results for the 52 weeks ending 29 March 2025, with its poultry division showing strong volume and revenue growth.
Total revenue reached £2.71 billion, up 4.4% from £2.6 billion in the previous financial year. Adjusted profit before tax increased by 12.1% to £197.9 million, reflecting gains in operational efficiency and a higher value product mix, particularly within poultry.
Cranswick’s poultry operations were a particular highlight, based around its processing plant in Eye, Suffolk. Though the financial results are not disclosed for the different parts of the business, the board acknowledged that poultry volume growth was again in the double digits, and significantly outpaced other categories.
Chief executive Adam Couch said: “Our poultry business continues to be a key growth driver for the business. We are investing close to £50 million to add incubatory capacity, lift processing capacity at Eye and significantly upscale our two added-value facilities in East Yorkshire.”
The company’s capital expenditure for the year totalled £137.6 million, much of which was directed toward ongoing upgrades at Eye and further poultry supply chain automation.
Cranswick said there would be continued expansion in added-value poultry lines, including marinated and seasoned SKUs.
Cranswick also maintained its commitment to rigorous biosecurity controls, especially amid continued detections of avian influenza (HPAI H5N1) across the UK. The company reiterated the importance of integrated operations in managing disease risk.